Pasithea Therapeutics Corp. (KTTAW) NASDAQ
0.01
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.01
+0(+0.00%)
Currency In USD
| Market Cap | 9.07M |
| Enterprise Value | -46.09M |
| P/E Ratio | -0.83 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2,355.44 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0 |
| Return On Equity | -0 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.19M |
| Net Income | -20.43M |
| Diluted EPS | -2.91 |
| Total Cash | 50.4M |
| Total Cash/Share | 2,070.85 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 35.4 |
| Book Value Per Share | 2,252.13 |
| 52-Week Change | -64 |
| 52-Week High | 0.01 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.02 |
| Average Volume | 25,406.38 |
| Shares Outstanding | 7.44M |
| % Held by Institutions | 6.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |